Noninvasive imaging of protein–protein interactions in living animals

Protein–protein interactions control transcription, cell division, and cell proliferation as well as mediate signal transduction, oncogenic transformation, and regulation of cell death. Although a variety of methods have been used to investigate protein interactions in vitro and in cultured cells, none can analyze these interactions in intact, living animals. To enable noninvasive molecular imaging of protein–protein interactions in vivo by positron-emission tomography and fluorescence imaging, we engineered a fusion reporter gene comprising a mutant herpes simplex virus 1 thymidine kinase and green fluorescent protein for readout of a tetracycline-inducible, two-hybrid system in vivo. By using micro-positron-emission tomography, interactions between p53 tumor suppressor and the large T antigen of simian virus 40 were visualized in tumor xenografts of HeLa cells stably transfected with the imaging constructs. Imaging protein-binding partners in vivo will enable functional proteomics in whole animals and provide a tool for screening compounds targeted to specific protein–protein interactions in living animals.

[1]  R. Esnouf,et al.  Characterization of multiple nuclear localization signals in herpes simplex virus type 1 thymidine kinase. , 1999, Biochemical and biophysical research communications.

[2]  A. Jacobs,et al.  Functional coexpression of HSV-1 thymidine kinase and green fluorescent protein: implications for noninvasive imaging of transgene expression. , 1999, Neoplasia.

[3]  B. Schaffhausen.  Transforming genes and gene products of polyoma and SV40. , 1982, CRC critical reviews in biochemistry.

[4]  R. DePinho,et al.  Use of the human EF-1alpha promoter for expression can significantly increase success in establishing stable cell lines with consistent expression: a study using the tetracycline-inducible system in human cancer cells. , 1999, Nucleic acids research.

[5]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[6]  M. Welch,et al.  Novel gallium(III) complexes transported by MDR1 P-glycoprotein: potential PET imaging agents for probing P-glycoprotein-mediated transport activity in vivo. , 2000, Chemistry & biology.

[7]  S. Cherry,et al.  Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  P. Friedman,et al.  Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.

[9]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Uetz,et al.  Towards an understanding of complex protein networks. , 2001, Trends in cell biology.

[11]  P. Conti,et al.  Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG): a new potential imaging agent for viral infection and gene therapy using PET. , 1998, Nuclear medicine and biology.

[12]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Piwnica-Worms,et al.  Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. , 1995, Biochemistry.

[14]  James F. Young,et al.  MicroPET: a high resolution PET scanner for imaging small animals , 1996, IEEE Nuclear Science Symposium Conference Record.

[15]  A. Varshavsky,et al.  Split ubiquitin as a sensor of protein interactions in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Mullins,et al.  Conditional transgenic technologies. , 2001, The Journal of endocrinology.

[17]  R. Blasberg,et al.  Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  B. Snel,et al.  Comparative assessment of large-scale data sets of protein–protein interactions , 2002, Nature.

[19]  S. Michnick,et al.  Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[21]  H. Blau,et al.  Monitoring protein-protein interactions in intact eukaryotic cells by beta-galactosidase complementation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Harter,et al.  The NAF domain defines a novel protein–protein interaction module conserved in Ca2+‐regulated kinases , 2001, The EMBO journal.

[23]  Y. Erdi,et al.  Standardized uptake value in pediatric patients: an investigation to determine the optimum measurement parameter , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  A. Aronheim,et al.  The Ras recruitment system, a novel approach to the study of protein–protein interactions , 1998, Current Biology.

[25]  G. Stark,et al.  How cells respond to interferons. , 1998, Annual review of biochemistry.

[26]  E. Golemis,et al.  Redefinition of the yeast two-hybrid system in dialogue with changing priorities in biological research. , 2001, BioTechniques.

[27]  M. Gossen,et al.  Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.

[28]  H. Shimada,et al.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  H. Blau,et al.  Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation. , 2000, Trends in cell biology.

[31]  S. Cherry,et al.  Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  E. Golemis,et al.  Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions. , 2001, Methods.

[33]  J. Barrio,et al.  Assays for noninvasive imaging of reporter gene expression. , 1999, Nuclear medicine and biology.

[34]  S. Elledge,et al.  Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions , 1997, Molecular and cellular biology.

[35]  Gary D Luker,et al.  Visualizing protein-protein interactions in living animals. , 2003, Methods.

[36]  R G Blasberg,et al.  Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. , 1996, Cancer research.

[37]  I. Wilson,et al.  Erythropoietin receptor activation by a ligand-induced conformation change. , 1999, Science.

[38]  S S Gambhir,et al.  Noninvasive quantitative imaging of protein–protein interactions in living subjects , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[40]  A. Galarneau,et al.  β-Lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein–protein interactions , 2002, Nature Biotechnology.

[41]  R. Blasberg,et al.  Imaging the expression of transfected genes in vivo. , 1995, Cancer research.

[42]  J. Bading,et al.  Preclinical evaluation of the penciclovir analog 9-(4-[(18)F]fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  David M. Livingston,et al.  A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells , 2002, Science.

[44]  P. Conti,et al.  9-[(3-[18F]-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG): a potential imaging agent of viral infection and gene therapy using PET. , 1996, Nuclear medicine and biology.

[45]  J. Leatherwood,et al.  A potent GAL4 derivative activates transcription at a distance in vitro. , 1990, Science.

[46]  M. Lewandoski.  Conditional control of gene expression in the mouse , 2001, Nature Reviews Genetics.

[47]  Blasberg Rg,et al.  Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy. , 1999 .

[48]  R. L. Jarvest,et al.  Synthesis and antiviral activity of 9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]purines. , 1987, Journal of medicinal chemistry.

[49]  Jan Tavernier,et al.  Design and application of a cytokine-receptor-based interaction trap , 2001, Nature Cell Biology.

[50]  Hailan Zhang,et al.  Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism , 1997, Molecular and cellular biology.

[51]  I. Stagljar,et al.  A genetic system based on split-ubiquitin for the analysis of interactions between membrane proteins in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[52]  M. Black,et al.  Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Milbrandt,et al.  In Vitro and In Vivo Characterization of a Dual-Function Green Fluorescent Protein–HSV1-Thymidine Kinase Reporter Gene Driven by the Human Elongation Factor 1α Promoter , 2002, Molecular imaging.

[54]  C. Heldin,et al.  Signal Transduction: Multiple Pathways, Multiple Options for Therapy , 2001, Stem cells.

[55]  S. Larson,et al.  Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer , 2001, Nature Medicine.